Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

European mutual recognition procedure completed for Estradot

Nov. 6, 2001

NDA submission for King's injectable estrogen replacement therapy

Nov. 6, 2001

SGLT2 inhibitors from Kissei useful for diabetes, obesity

Nov. 5, 2001

Preparation and use of 1,5-benzothiazepines that inhibit bile acid transport

Nov. 5, 2001

New agents for osteoporosis in the AxyS pipeline

Nov. 5, 2001

Inhibitors of hormone-sensitive lipase (HSL) useful in diabetes and related disorders

Oct. 31, 2001

New imidazoles jointly described by Novo Nordisk and Boehringer Ingelheim as H3 ligands

Oct. 31, 2001

Ariad designs new series of Src kinase SH2 antagonists

Oct. 31, 2001

NN-622 development continues without Novartis

Oct. 31, 2001

Fabrazyme available to Fabry's disease patients in several E.U. countries

Oct. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...